论文部分内容阅读
美国食品和药品管理局(FDA),日本和欧盟在化妆品管理方面已有一些重要变化,这些变化将影响化妆品在这些国家的销售。日本的补充说明和欧盟消费品科学委员会(SCCP)提出的安全问题,由于放宽了曾经限制的成份,需要改进安全评价或改变标示的要求。这些将会影响世界化妆品配制者的工作。
The United States Food and Drug Administration (FDA), Japan and the European Union have some important changes in cosmetics management that will affect the sales of cosmetics in these countries. Japan’s supplementary note and the safety issues raised by the European Commission for Consumer Products Science (SCCP), due to loosening of previously restricted ingredients, require improvements in safety assessment or changes in the labeling requirements. These will affect the work of the world’s cosmetics formulators.